IMC Chicago’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.71M Buy
1,231,300
+244,500
+25% +$1.37M ﹤0.01% 1565
2025
Q4
$6.91M Sell
986,800
-65,300
-6% -$511K ﹤0.01% 1496
2025
Q3
$8.13M Buy
1,052,100
+428,500
+69% +$3.34M ﹤0.01% 1261
2025
Q2
$5.43M Sell
623,600
-206,200
-25% -$1.49M ﹤0.01% 1337
2025
Q1
$6.61M Sell
829,800
-43,500
-5% -$440K ﹤0.01% 1074
2024
Q4
$7.94M Buy
873,300
+54,800
+7% +$529K ﹤0.01% 1027
2024
Q3
$7.51M Buy
818,500
+239,100
+41% +$1.98M ﹤0.01% 949
2024
Q2
$5.67M Buy
579,400
+261,100
+82% +$3.18M ﹤0.01% 1008
2024
Q1
$4.81M Sell
318,300
-259,500
-45% -$4.71M ﹤0.01% 986
2023
Q4
$12.5M Sell
577,800
-10,600
-2% -$196K 0.01% 590
2023
Q3
$10.9M Buy
588,400
+264,700
+82% +$6.18M 0.01% 536
2023
Q2
$8.2M Sell
323,700
-94,000
-23% -$2.37M 0.01% 555
2023
Q1
$10.8M Sell
417,700
-338,800
-45% -$9.07M 0.01% 467
2022
Q4
$17.9M Buy
756,500
+7,200
+1% +$194K 0.03% 331
2022
Q3
$19M Sell
749,300
-1,000
-0.1% -$35.1K 0.02% 298
2022
Q2
$24.9M Buy
750,300
+110,200
+17% +$4.68M 0.04% 240
2022
Q1
$46.2M Sell
640,100
-25,500
-4% -$1.84M 0.05% 178
2021
Q4
$61.1M Buy
665,600
+211,900
+47% +$25.3M 0.05% 167
2021
Q3
$57.5M Buy
453,700
+9,600
+2% +$1.4M 0.06% 166
2021
Q2
$73.8M Sell
444,100
-7,200
-2% -$1.17M 0.09% 120
2021
Q1
$82M Buy
451,300
+176,500
+64% +$40.9M 0.12% 86
2020
Q4
$54.9M Buy
274,800
+127,500
+87% +$25.9M 0.07% 121
2020
Q3
$32.3M Buy
147,300
+63,100
+75% +$13.4M 0.05% 126
2020
Q2
$16.1M Buy
84,200
+56,700
+206% +$9.94M 0.03% 196
2020
Q1
$4.26M Buy
+27,500
New +$3.2M 0.01% 355

Other funds holding TDOC

IMC Chicago's TDOC Position: Q1 2026 in Review

IMC Chicago sold out of Teladoc Health (TDOC) in Q1 2026, closing a stake of 235,521 shares — an estimated $1.32M sold.

IMC Chicago first reported a position in TDOC in Q1 2021 and held it in 14 quarters. The position peaked at $5.21M in Q2 2025. 322 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

  • IMC Chicago reported no remaining Teladoc Health position as of Q1 2026 after selling out during the quarter.
  • IMC Chicago sold 235,521 Teladoc Health shares in Q1 2026, an estimated $1.32M.
  • IMC Chicago first reported a position in Teladoc Health in Q1 2021 and held it in 14 quarters.
  • IMC Chicago's Teladoc Health position peaked at $5.21M in Q2 2025.
  • 322 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.